150 related articles for article (PubMed ID: 9299249)
1. Establishment and characterization of human ovarian carcinoma cell lines.
Yuan Y; Kim WH; Han HS; Lee JH; Park HS; Chung JK; Kang SB; Park JG
Gynecol Oncol; 1997 Sep; 66(3):378-87. PubMed ID: 9299249
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of four human pancreatic carcinoma cell lines. Genetic alterations in the TGFBR2 gene but not in the MADH4 gene.
Ku JL; Yoon KA; Kim WH; Jang Y; Suh KS; Kim SW; Park YH; Park JG
Cell Tissue Res; 2002 May; 308(2):205-14. PubMed ID: 12037578
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of cell lines derived from uterine malignant mixed Müllerian tumor.
Yuan Y; Kim WH; Han HS; Lee JH; Park HS; Chung JK; Kang SB; Park JG
Gynecol Oncol; 1997 Sep; 66(3):464-74. PubMed ID: 9299262
[TBL] [Abstract][Full Text] [Related]
4. Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma.
Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ
Gynecol Oncol; 2000 Jul; 78(1):10-5. PubMed ID: 10873402
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of a novel BRCA1-null ovarian cancer cell line in response to ionizing radiation.
DelloRusso C; Welcsh PL; Wang W; Garcia RL; King MC; Swisher EM
Mol Cancer Res; 2007 Jan; 5(1):35-45. PubMed ID: 17259345
[TBL] [Abstract][Full Text] [Related]
6. p53 gene mutation analysis and antisense-mediated growth inhibition of human ovarian carcinoma cell lines.
Skilling JS; Squatrito RC; Connor JP; Niemann T; Buller RE
Gynecol Oncol; 1996 Jan; 60(1):72-80. PubMed ID: 8557231
[TBL] [Abstract][Full Text] [Related]
7. p53 mutation is infrequent in clear cell carcinoma of the ovary.
Ho ES; Lai CR; Hsieh YT; Chen JT; Lin AJ; Hung MH; Liu FS
Gynecol Oncol; 2001 Feb; 80(2):189-93. PubMed ID: 11161858
[TBL] [Abstract][Full Text] [Related]
8. p53 mutations in bladder carcinoma cell lines.
Cooper MJ; Haluschak JJ; Johnson D; Schwartz S; Morrison LJ; Lippa M; Hatzivassiliou G; Tan J
Oncol Res; 1994; 6(12):569-79. PubMed ID: 7787250
[TBL] [Abstract][Full Text] [Related]
9. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.
Wu R; Zhai Y; Fearon ER; Cho KR
Cancer Res; 2001 Nov; 61(22):8247-55. PubMed ID: 11719457
[TBL] [Abstract][Full Text] [Related]
10. Establishment and characterization of cell lines from three human thyroid carcinomas: responses to all-trans-retinoic acid and mutations in the BRAF gene.
Koh CS; Ku JL; Park SY; Kim KH; Choi JS; Kim IJ; Park JH; Oh SK; Chung JK; Lee JH; Kim WH; Kim CW; Cho BY; Park JG
Mol Cell Endocrinol; 2007 Jan; 264(1-2):118-27. PubMed ID: 17134824
[TBL] [Abstract][Full Text] [Related]
11. Abnormal structure and expression of the p53 gene in human ovarian carcinoma cell lines.
Yaginuma Y; Westphal H
Cancer Res; 1992 Aug; 52(15):4196-9. PubMed ID: 1638534
[TBL] [Abstract][Full Text] [Related]
12. Allelic imbalance and microsatellite instability in BRCA1 associated breast and ovarian tumors.
van der Looij M; Papp J; Sztán M; Pulay T; Elfadil I; Besznyak I; Tóth J; Devilee P; Oláh E
Int J Oncol; 2001 Apr; 18(4):775-80. PubMed ID: 11251173
[TBL] [Abstract][Full Text] [Related]
13. An abundance of p53 null mutations in ovarian carcinoma.
Skilling JS; Sood A; Niemann T; Lager DJ; Buller RE
Oncogene; 1996 Jul; 13(1):117-23. PubMed ID: 8700537
[TBL] [Abstract][Full Text] [Related]
14. BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study.
Baldwin RL; Nemeth E; Tran H; Shvartsman H; Cass I; Narod S; Karlan BY
Cancer Res; 2000 Oct; 60(19):5329-33. PubMed ID: 11034065
[TBL] [Abstract][Full Text] [Related]
15. Mutations of the E-cadherin gene in human gynecologic cancers.
Risinger JI; Berchuck A; Kohler MF; Boyd J
Nat Genet; 1994 May; 7(1):98-102. PubMed ID: 8075649
[TBL] [Abstract][Full Text] [Related]
16. SNU cell lines and their application for cancer research.
Park JG
Gan To Kagaku Ryoho; 2002 Feb; 29 Suppl 1():89-98. PubMed ID: 11890121
[TBL] [Abstract][Full Text] [Related]
17. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
[TBL] [Abstract][Full Text] [Related]
18. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
19. Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations.
Havrilesky LJ; Alvarez AA; Whitaker RS; Marks JR; Berchuck A
Gynecol Oncol; 2001 Dec; 83(3):491-500. PubMed ID: 11733961
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomas.
Arnold JM; Mok SC; Purdie D; Chenevix-Trench G
Br J Cancer; 2001 Feb; 84(3):352-9. PubMed ID: 11161400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
